EARLY METABOLIC CHANGES WITH THIAZIDE OR BETA BLOCKER THERAPY FOR ESSENTIAL HYPERTENSION (MAIN STUDY). - METABOLIC CHANGES WITH THIAZIDE OR BETA BLOCKER THERAPY

Phase 1

• Conditions: ESSENTIAL HYPERTENSIO

• Registration Number: EUCTR2004-004329-90-GB
• Lead Sponsor: CAMBRIDGE UNIVERSITY HOSPITALS FOUNDATION NHS TRUST

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2005-02-15
• Study Completion: 2010-11-17
• Last Update Posted: 30 June 2019

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

-patients are hypertensive
-aged 18-75yrs
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

-patients with diabetes
-patients who have been previously intolerant to any of the study drugs
-patients already on any of the study drugs and unable to change to an alternative

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified